US · Healthcare

Harvard Bioscience Inc (HBIO)

Medical Instruments & Supplies

Harvard Bioscience Inc (HBIO) is listed on US in the Healthcare sector. Industry: Medical Instruments & Supplies. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for HBIO

P/E ratio

18.00

Harvard Bioscience Inc (HBIO) — FAQ

What is HBIO's P/E ratio?

The price-to-earnings (P/E) ratio for Harvard Bioscience Inc (HBIO) is 18.00 (data as of 2026-05-23).

Does Harvard Bioscience Inc pay a dividend?

Dividend yield is not available in the current snapshot for Harvard Bioscience Inc (HBIO). Check the MyAverix Finance app for the latest dividend data.

What sector is Harvard Bioscience Inc in?

Harvard Bioscience Inc (HBIO) is classified in the Healthcare sector (Medical Instruments & Supplies industry).

What exchange is HBIO listed on?

HBIO is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)